why choose us

Clinical Trials Search

Showing 4,030 of 132,656 result(s)
The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine

Status: COMPLETED

Condition: Influenza

Interventions: This vaccine is produced by Changchun BCHT Biotechnology Co.

Date: 2024-09-13

A Phase Ib Study of AZD5462 on Top of Dapagliflozin in Participants With Heart Failure and Moderate Renal Impairment

Status: COMPLETED

Condition: Renal Impairment

Interventions: Participants will receive AZD5462 on top of dapagliflozin once daily.

Date: 2024-09-13

Comparison of SPECT;CT Perfusion and Volumetric CT Volume

Status: COMPLETED

Condition: Lung Cancer (NSCLC)

Interventions: Use the SPECT;CT to predict pulmonary function

Date: 2024-09-13

Comparison of SPECT;CT Perfusion and Volumetric CT Volume

Status: COMPLETED

Condition: Lung Cancer (NSCLC)

Interventions: Use the SPECT;CT to predict pulmonary function

Date: 2024-09-13

Post-Operative Physical Activity Monitoring: Algorithm Performance and Clinical Outcomes

Status: COMPLETED

Condition: Postoperative Period

Interventions:

Date: 2024-09-13

Integrated Neuromuscular Inhibition Versus Cervical and Scapular Stabilization Exercises on Myofascial Trigger Points of Upper Trapezius

Status: COMPLETED

Condition: Trigger Point Pain, Myofascial

Interventions: a device that transmit ultrasound waves to the participant through direct contact

Date: 2024-09-12

The Safety and Effectiveness of Warfarin Vs Apixaban in Patients with NVAF; VTE and ESKD on Dialysis

Status: COMPLETED

Condition: End-Stage Kidney Disease (ESKD)

Interventions: Apixaban is a direct oral anticoagulant (DOAC) that inhibits factor Xa, playing a crucial role in preventing blood clot formation.
It is commonly

Date: 2024-09-12

A Clinical Study to Assess the Effect of Enlicitide on How the Body Processes Digoxin in Healthy Adult Participants (MK-0616-031)

Status: COMPLETED

Condition: Healthy

Interventions: Participants will receive 20 mg enlicitide;180 mg sodium caprate coadministered with 0.25mg Digoxin orally on Day 1, Period 2 in Arm A and on Day

Date: 2024-09-12

A Study of LY4100511 (DC-853) Mass Balance and Absolute Bioavailability of LY4100511 in Healthy Male Participants

Status: COMPLETED

Condition: Healthy

Interventions: Administered oral dose

Date: 2024-09-12

Effect of Different Stretching Techniques

Status: COMPLETED

Condition: Cerebral Palsy

Interventions: Subjects lay supine on a treatment table, holding one knee to the chest and letting the other leg extend freely toward the floor at the end of the tab

Date: 2024-09-12